Skip to main content
SP5007,674.37+0.43%DOW53,277.01+0.98%NASDAQ26,180.46+0.43%BTC$77,812.00+5.53%ETH$2,513.75+7.22%GOLD$4,661.60+1.97%OIL$86.64-0.22%
Smart Investors Daily
Sign InSign Up Free
ST

OTC · STEK

Stemtech Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Up+$0.00 (+0.00%)

Updated Aug 24, 2026, 2:09 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
263.12K
P/E ratio
-0.13
Dividend yield
0.00%
52-week range
— – —
Volume
50K
Avg. volume
4.58M

Price performance

STEK price history

1M range · 0 trading sessions · Daily adjusted prices

STEK does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest STEK news

The latest Smart Investors Daily articles mentioning STEK.

Stock researchCompany · Overview

STEK research

Overview

Company profile and research snapshot.

Company profile

STEMTECH CORP

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

accessnewswire.com · Oct 27, 2025

Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic joint venture, creating Stemtech HealthSciences India Pvt Ltd, a subsidiary of Stemtech Corporation, a Nevada company (OTCQB:STEK). The India Market Stemtech Corporation Chairman & CEO, Charles S.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By